BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21440241)

  • 1. [Primary cutaneous melanoma: prognostic factors not included in the classification of the American Joint Committee on Cancer].
    Tejera-Vaquerizo A; Solís-García E; Ríos-Martín JJ; Moreno-Ramírez D
    Actas Dermosifiliogr; 2011 May; 102(4):255-63. PubMed ID: 21440241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
    Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some of the 2009 American Joint Committee on Cancer melanoma staging and classification is not evidence based.
    Thomas JM; Strauss DC; Hayes AJ
    J Clin Oncol; 2010 Sep; 28(27):e479; author reply e480-1. PubMed ID: 20566996
    [No Abstract]   [Full Text] [Related]  

  • 4. Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma.
    Retsas S; Mastrangelo MJ
    Semin Oncol; 2007 Dec; 34(6):491-7. PubMed ID: 18083372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current melanoma staging.
    Petro A; Schwartz J; Johnson T
    Clin Dermatol; 2004; 22(3):223-7. PubMed ID: 15262308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.
    Gimotty PA; Guerry D; Ming ME; Elenitsas R; Xu X; Czerniecki B; Spitz F; Schuchter L; Elder D
    J Clin Oncol; 2004 Sep; 22(18):3668-76. PubMed ID: 15302909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
    Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
    J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The new TNM classification of malignant melanoma].
    Oláh J; Dobozy A
    Magy Onkol; 2003; 47(1):59-61. PubMed ID: 12704456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients.
    Nading MA; Balch CM; Sober AJ
    Semin Cutan Med Surg; 2010 Sep; 29(3):142-7. PubMed ID: 21051007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma.
    Busam KJ
    Am J Clin Pathol; 2001 May; 115(5):743-6. PubMed ID: 11345839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U; Buettner PG; Eigentler TK; Garbe C
    J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
    Gimotty PA; Botbyl J; Soong SJ; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
    Balch CM; Buzaid AC; Soong SJ; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
    Semin Surg Oncol; 2003; 21(1):43-52. PubMed ID: 12923915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for melanoma.
    Wisco OJ; Sober AJ
    Dermatol Clin; 2012 Jul; 30(3):469-85. PubMed ID: 22800552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.
    Ben-Porat L; Panageas KS; Hanlon C; Patel A; Halpern A; Houghton AN; Coit D
    Cancer; 2006 Jan; 106(1):163-71. PubMed ID: 16331596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New American Joint Commission on Cancer staging system for melanoma: prognostic impact and future directions.
    Ross MI
    Surg Oncol Clin N Am; 2006 Apr; 15(2):341-52. PubMed ID: 16632219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification and staging of melanoma.
    Gershenwald JE; Buzaid AC; Ross MI
    Clin Lab Med; 2000 Dec; 20(4):785-815. PubMed ID: 11221515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in patients with localized primary cutaneous melanoma.
    Mervic L
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):27-31. PubMed ID: 23000937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2010 TNM staging system for cutaneous melanoma...and beyond.
    Gershenwald JE; Soong SJ; Balch CM;
    Ann Surg Oncol; 2010 Jun; 17(6):1475-7. PubMed ID: 20300965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.